RxDoctor Payments Data

Teresa Wilson, NP

Family · Douglas, GANPI 1710269220

Payments from drug & device makers

$8,736in general payments, 2019–2025

Across 411 payments — averaging $21.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$1K
  • AbbVie$1K
  • Novo Nordisk$779
  • Corcept Therapeutics$714
  • Amgen$596
  • AstraZeneca$532
  • plus $4K from 38 others

What the payments were for

  • Food & beverage$8,56898%
  • Education$1692%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,736 in reported general payments places this provider in the 95th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Medicare billing

Part B allowed, 2024
$72,544
Medicare patients
224
Services billed
2,822

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
KorlymMifepristone22$559,264
MounjaroTirzepatide328$364,510
OzempicSemaglutide166$185,935
EliquisApixaban209$153,388
FarxigaDapagliflozin Propanediol183$141,793
Trelegy ElliptaFluticasone/Umeclidin/Vilanter141$122,200
LinzessLinaclotide181$108,704
VraylarCariprazine Hcl59$88,440
JardianceEmpagliflozin107$84,728
JanuviaSitagliptin Phosphate65$47,576
RybelsusSemaglutide38$42,801
EntrestoSacubitril/Valsartan39$37,931
MyrbetriqMirabegron47$32,305
Breztri AerosphereBudesonide/Glycopyr/Formoterol42$26,809
Tresiba Flextouch U-100Insulin Degludec45$24,763

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Corcept TherapeuticsKorlym$714$559,26422 claims
Lilly USA, LLCMounjaro, Trulicity$109$387,909348 claims
Novo NordiskOzempic, Rybelsus, Wegovy$779$251,008221 claims
AbbVieLinzess, Vraylar$1,023$197,144240 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort, Bevespi Aerosphere$532$185,393287 claims
PfizerEliquis, Nurtec Odt$227$170,004220 claims
GSKTrelegy Ellipta$1,200$122,200141 claims
Boehringer IngelheimJardiance, Stiolto Respimat$63$95,818130 claims
MerckJanuvia$234$47,57665 claims
NovartisEntresto$118$37,93139 claims
Astellas Pharma US IncMyrbetriq$287$32,30547 claims
Sanofi-aventis U.S. LLCMultaq, Lantus$17$16,24152 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,258 family providers in Georgia.

Other family in Douglas

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →